Literature DB >> 3559392

Characterization of inositol lipids from Leishmania donovani promastigotes: identification of an inositol sphingophospholipid.

E S Kaneshiro, K Jayasimhulu, R L Lester.   

Abstract

Inositol lipids account for 15% of the total cellular phospholipids of Leishmania donovani promastigotes. Four major inositol lipids were identified and characterized: phosphatidylinositol (PI), phosphatidylinositol phosphate (PI-P), phosphatidylinositol diphosphate (PI-P2), and an inositol sphingophospholipid (InSL). Diacyl and alkyl acyl PI were identified. The major esterified fatty acids of PI, PI-P, and PI-P2 were similar and unlike those of mammalian inositol glycerolipids. Leishmania inositol glycerolipids contained only trace amounts of arachidonic acid; the major species were C16 and C18 acids. The InSL comprised about 40% of the inositol lipids. The amide-linked fatty acids of InSL were mainly C16 and C18 acids. Differential hydrolysis and nuclear magnetic resonance spectrometry indicated that the InSL had a phosphoryl bond. The major long chain bases of the InSL were identified by gas-liquid chromatography and high resolution mass spectrometry as straight chain C16 and C18 sphingosines. The finding of InSL in Leishmania is of interest because InSL have previously been found only in plants and fungi. Metabolic radiolabeling experiments suggest that this lipid may be a precursor of an antigenic cell surface membrane lipophosphoglycan which is shed into the culture medium by the organism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3559392

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Cell-free synthesis and functional characterization of sphingolipid synthases from parasitic trypanosomatid protozoa.

Authors:  Elitza S Sevova; Michael A Goren; Kevin J Schwartz; Fong-Fu Hsu; John Turk; Brian G Fox; James D Bangs
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.

Authors:  Shaheen S Sutterwala; Caleb H Creswell; Sumana Sanyal; Anant K Menon; James D Bangs
Journal:  Eukaryot Cell       Date:  2007-01-12

4.  A novel sphingophosphonolipid head group 1-hydroxy-2-aminoethyl phosphonate in Bdellovibrio stolpii.

Authors:  Y Watanabe; M Nakajima; T Hoshino; K Jayasimhulu; E E Brooks; E S Kaneshiro
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

5.  Developmentally regulated sphingolipid synthesis in African trypanosomes.

Authors:  Shaheen S Sutterwala; Fong-Fu Hsu; Elitza S Sevova; Kevin J Schwartz; Kai Zhang; Phillip Key; John Turk; Stephen M Beverley; James D Bangs
Journal:  Mol Microbiol       Date:  2008-08-11       Impact factor: 3.501

Review 6.  Phospholipid and sphingolipid metabolism in Leishmania.

Authors:  Kai Zhang; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-12-23       Impact factor: 1.759

Review 7.  Biochemistry of the Leishmania species.

Authors:  R H Glew; A K Saha; S Das; A T Remaley
Journal:  Microbiol Rev       Date:  1988-12

8.  Structural analysis of a glycosylphosphatidylinositol glycolipid of Leishmania donovani.

Authors:  D Sevlever; P Påhlsson; G Rosen; B Nilsson; M V Londner
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

9.  Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.

Authors:  Kai Zhang; Fong-Fu Hsu; David A Scott; Roberto Docampo; John Turk; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

Review 10.  Sphingolipids in parasitic protozoa.

Authors:  Kai Zhang; James D Bangs; Stephen M Beverley
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.